Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat

Abstract Serum levels of the pro-inflammatory apolipoprotein CIII (apoCIII) are increased in type-1 diabetic (T1D) patients and when β-cells are exposed to apoCIII they undergo apoptosis, which can be prevented by an antibody against apoCIII. We have previously investigated the BB rat, an animal mod...

Full description

Bibliographic Details
Main Authors: Karin Åvall, Per-Olof Berggren, Lisa Juntti-Berggren
Format: Article
Language:English
Published: BMC 2018-12-01
Series:Laboratory Animal Research
Subjects:
Online Access:http://link.springer.com/article/10.5625/lar.2018.34.3.126
_version_ 1818019839802867712
author Karin Åvall
Per-Olof Berggren
Lisa Juntti-Berggren
author_facet Karin Åvall
Per-Olof Berggren
Lisa Juntti-Berggren
author_sort Karin Åvall
collection DOAJ
description Abstract Serum levels of the pro-inflammatory apolipoprotein CIII (apoCIII) are increased in type-1 diabetic (T1D) patients and when β-cells are exposed to apoCIII they undergo apoptosis, which can be prevented by an antibody against apoCIII. We have previously investigated the BB rat, an animal model that develops a human-like T1D at the age of around 60 days, and found that apoCIII was also increased in sera from pre-diabetic rats and this promoted β-cell death. Lowering apoCIII with an oligonucleotide antisense during a phase of the pre-diabetic period prolonged the time to onset of T1D. In order to find other ways to lower apoCIII we in this study tested non-alcoholic red wine with medium and high concentrations of polyphenols and the lipid-lowering drug, fenofibrate, both reported to decrease the expression of apoCIII by activating peroxisome proliferator-activated receptors. Pre-diabetic BB-rats were treated orally for one month prior to the expected onset of diabetes with the two different wines or fenofibrate. None of the treatments prevented or prolonged the time to onset of diabetes and the expression of apoCIII was unaffected in this animal model for T1D. However, it must be emphasized that this does not exclude that other species can show a response to these substances.
first_indexed 2024-04-14T07:56:52Z
format Article
id doaj.art-98d2e8fcf82c49deba4974996ca12354
institution Directory Open Access Journal
issn 2233-7660
language English
last_indexed 2024-04-14T07:56:52Z
publishDate 2018-12-01
publisher BMC
record_format Article
series Laboratory Animal Research
spelling doaj.art-98d2e8fcf82c49deba4974996ca123542022-12-22T02:05:01ZengBMCLaboratory Animal Research2233-76602018-12-0134312613110.5625/lar.2018.34.3.126Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB ratKarin Åvall0Per-Olof Berggren1Lisa Juntti-Berggren2The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1Abstract Serum levels of the pro-inflammatory apolipoprotein CIII (apoCIII) are increased in type-1 diabetic (T1D) patients and when β-cells are exposed to apoCIII they undergo apoptosis, which can be prevented by an antibody against apoCIII. We have previously investigated the BB rat, an animal model that develops a human-like T1D at the age of around 60 days, and found that apoCIII was also increased in sera from pre-diabetic rats and this promoted β-cell death. Lowering apoCIII with an oligonucleotide antisense during a phase of the pre-diabetic period prolonged the time to onset of T1D. In order to find other ways to lower apoCIII we in this study tested non-alcoholic red wine with medium and high concentrations of polyphenols and the lipid-lowering drug, fenofibrate, both reported to decrease the expression of apoCIII by activating peroxisome proliferator-activated receptors. Pre-diabetic BB-rats were treated orally for one month prior to the expected onset of diabetes with the two different wines or fenofibrate. None of the treatments prevented or prolonged the time to onset of diabetes and the expression of apoCIII was unaffected in this animal model for T1D. However, it must be emphasized that this does not exclude that other species can show a response to these substances.http://link.springer.com/article/10.5625/lar.2018.34.3.126Apolipoprotein CIIIred winefenofibratediabetes
spellingShingle Karin Åvall
Per-Olof Berggren
Lisa Juntti-Berggren
Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
Laboratory Animal Research
Apolipoprotein CIII
red wine
fenofibrate
diabetes
title Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
title_full Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
title_fullStr Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
title_full_unstemmed Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
title_short Neither polyphenol-rich red wine nor fenofibrate affects the onset of type-1 diabetes mellitus in the BB rat
title_sort neither polyphenol rich red wine nor fenofibrate affects the onset of type 1 diabetes mellitus in the bb rat
topic Apolipoprotein CIII
red wine
fenofibrate
diabetes
url http://link.springer.com/article/10.5625/lar.2018.34.3.126
work_keys_str_mv AT karinavall neitherpolyphenolrichredwinenorfenofibrateaffectstheonsetoftype1diabetesmellitusinthebbrat
AT perolofberggren neitherpolyphenolrichredwinenorfenofibrateaffectstheonsetoftype1diabetesmellitusinthebbrat
AT lisajunttiberggren neitherpolyphenolrichredwinenorfenofibrateaffectstheonsetoftype1diabetesmellitusinthebbrat